Massive new program aims to tame Nigeria's hypertension crisis

NCT ID NCT07351162

Not yet recruiting Disease control Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study expands a successful blood pressure program to 50 primary health centers across five Nigerian states. Over 10,000 adults with high blood pressure will receive simplified care from trained non-physician health workers, following the WHO HEARTS package. The goal is to improve blood pressure control and keep it under control long-term.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WHO HEARTS Hypertension Treatment Bundle (training, simplified guidelines, non-physician care, audit/feedback)
What this could lead to: If successful, this could show a practical way to control high blood pressure in low-resource communities, reducing heart attacks and strokes.
What could go wrong: This is an implementation study, not testing a new drug. Success depends on local health systems and may not apply to other regions. Blood pressure control requires lifelong management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION (HTN)

More trials for these conditions

Other studies related to the condition(s) this trial covers.